ABCL: AbCellera Biologics Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
PEG koeffitsiyenti xaridorlar va sotuvchilar o'rtasidagi kurashni namoyish etadi, bunda 0.00 yangi darajani ifodalaydi. AbCellera Biologics (ABCL) narxlarining dinamikasi makroiqtisodiyotdan mustaqil qolmoqda, chunki foyda royalti to'lovlari va tadqiqot bosqichlariga asoslangan. AbCellera Biologics (ABCL) B2B sektorida antitanalarni tezlashtirilgan holda kashf qilish uchun AI texnologiyasidan foydalanadi. Laboratoriyalar uchun biokomponentlar ta'minotining xalqaro diversifikatsiyasi barqarorlikni ta'minlaydi.
AbCellera (ABCL) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati AbCellera Biologics|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi AbCellera Biologics Inc.|ABCL - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar AbCellera Corp|ABCL - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari AbCellera|Tezkor likvidlik abcellera.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ABCL - Sof foyda|Kelajakdagi foyda AbCellera Biologics|ABCL - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati AbCellera Bio|ABCL - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati AbCellera Corp|ABCL - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda AbCellera|ABCL - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi abcellera.com|ABCL - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi AbCellera Biologics
Kompaniyaning umumiy tahlili:ABCL - AbCellera Corp
Hamkorlarning R&D budjetlarining qisqarishi AbCellera Biologics (ABCL) daromadlariga bosim o'tkazmoqda, garchi sezilarli likvidlik rezervi operatsion barqarorlikni ta'minlasa-da. peg_co koeffitsiyenti aktivlarning qadrsizlanganini aniqlash uchun joriy P/E koeffitsiyentini foyda o'sish sur'atlari bilan solishtiradi; ushbu koeffitsiyentning birdan pastga tushishi kompaniyaning kengayish dinamikasi va bozor kapitalizatsiyasiga nisbatan yuqori investitsiya jozibadorligidan dalolat beradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|PHVS - PEG multiplikatori|TRML: PEG multiplikatori|PGEN (precigen.com) - Narxning foydaga va o‘sish sur’atiga nisbati|PHAR (Pharming Group) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Nektar Therapeutics Inc (NKTR)|PEG multiplikatori UPB|ZBIO - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Immunome, Inc. IMNM|gossamerbio.com - Narxning foydaga va o‘sish sur’atiga nisbati|KALV - Narxning foydaga va o‘sish sur’atiga nisbati|SEPN: Narxning foydaga va o‘sish sur’atiga nisbati|PVLA: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Savara Pharma (SVRA)|Narxning foydaga va o‘sish sur’atiga nisbati Rigel Pharmaceuticals|ANAB: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ATXS|PEG multiplikatori enGene Holdings Inc (ENGN)|RAPT Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti JBIO|Aclaris Therapeutics - PEG multiplikatori|KYTX: Narxning foydaga va o‘sish sur’atiga nisbati|TLSA: PEG multiplikatori|CABA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Ventyx Bio|O‘sish sur’atiga tuzatilgan narx-foyda Theratechnologies, Inc THTX|Narxning foydaga va o‘sish sur’atiga nisbati Avalo Therapeutics, Inc (AVTX)|Narxning foydaga va o‘sish sur’atiga nisbati ELDN (eledon.com)|Narxning foydaga va o‘sish sur’atiga nisbati Agenus Inc. AGEN|Climb Bio Inc. (CLYM) - O‘sish sur’atiga tuzatilgan narx-foyda|Zura Bio Limited - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati aTyr Pharmaceuticals (ATYR)|ADAG: PEG multiplikatori|IMA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|STTK (Shattuck Labs Inc) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Equillium Bio (EQ)|Narxning foydaga va o‘sish sur’atiga nisbati Connect Biopharma (CNTB)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati immunic-therapeutics.com|PEG multiplikatori ATRA (Atara Bio)|PEG multiplikatori InflaRx NV IFRX|X4 Pharmaceuticals, Inc. - PEG multiplikatori|ACET: Narxning foydaga va o‘sish sur’atiga nisbati|CELU: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori INmune Bio Corporation|Narxning foydaga va o‘sish sur’atiga nisbati Barinthus Biotherapeutics|Narxning foydaga va o‘sish sur’atiga nisbati KZR|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|AKTX: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti QTTB|GeoVax Labs, Inc. - PEG multiplikatori|EDSA - PEG multiplikatori|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Carisma Therapeutics Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati XTL Biopharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori Bolt Bio (BOLT)|PEG multiplikatori HCWB|PEG multiplikatori aptevotherapeutics.com (APVO)|AIM ImmunoTech - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADTX|GRI Bio Corp - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati XORTX Corp XRTX|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori revbiosciences.com|Narxning foydaga va o‘sish sur’atiga nisbati Indaptus Therapeutics, Inc.|Narx-foyda va o‘sish multiplikatori Scinai Immunotherapeutics Ltd (SCNI)|Narx-foyda va o‘sish multiplikatori CALI (CalciMedica, Inc.)|PEG multiplikatori affimed.com (AFMD)|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IGM Bio - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda iTeos Therapeutics Inc|OCEA: PEG multiplikatori|TC BioPharm Ltd (TCBP) - PEG multiplikatori|THRD (Third Harmonic Bio) - PEG multiplikatori
